{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:32Z","timestamp":1783347872628,"version":"3.54.6"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Oral squamous cell carcinoma (OSCC), the most common malignancy, involves molecular alterations including p53 mutations, TGF-\u03b1, and EGFR overexpression. Targeting biomarkers is essential for effective therapy. Cytisine, a natural smoking-cessation alkaloid with diverse pharmacological activities, was evaluated using bioinformatics to identify potential anticancer targets and subsequently validated\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The in silico analysis included predictions of toxicity, drug-likeness, and potential targets for cytisine. OSCC-associated targets were retrieved from GeneCards and ACTREC databases. Cytoscape was used to construct cytisine-target pathways. Molecular docking and 100 ns molecular dynamics simulations were performed to evaluate cytisine binding affinity and structural stability to key targets. The\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      validation was performed using the MTT assay and cell migration assay on an epithelial carcinoma cell model (KB-3-1 cell line).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Cytisine was non-toxic and modulated 23 target proteins and 13 signalling pathways. Gene enrichment analysis revealed significant interactions with EGFR and TP53. Molecular docking and 100 ns molecular dynamics simulation showed strong intermolecular interactions and low binding energies with EGFR (\u22126.9 kcal\/mol) and TP53 (\u22127.7 kcal\/mol) compared with standard drugs.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      assays demonstrated significant cytotoxicity and inhibition of cell migration in epithelial carcinoma cell lines while maintaining the viability of L929 normal fibroblast cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Cytisine exhibits strong interactions and lower binding energies with EGFR and TP53, and cytotoxic and anti-migratory effects against the epithelial carcinoma cell model. However, further validation using primary oral squamous carcinoma cell lines and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      studies is necessary to confirm its therapeutic relevance to epithelial carcinoma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_86_26","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:00:13Z","timestamp":1783101613000},"page":"258-269","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the anticancer effect of cytisine against oral cancer: Insights from bioinformatics and in-vitro approaches"],"prefix":"10.4103","volume":"30","author":[{"given":"Savita S.","family":"Thakkannavar","sequence":"first","affiliation":[{"name":"Oral Pathology and Microbiology, KLE VK Institute of Dental Sciences, KLE Academy of Higher Education and Research (KAHER), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa R.","family":"Mane","sequence":"additional","affiliation":[{"name":"Oral Pathology and Microbiology, KLE VK Institute of Dental Sciences, KLE Academy of Higher Education and Research (KAHER), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Beerwala","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research- National Institute of Traditional Medicine, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish R.","family":"Darasaguppe","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research- National Institute of Traditional Medicine, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahana","family":"Shahpuri","sequence":"additional","affiliation":[{"name":"Dr Prabhakar Kore Basic Science Research Center, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"R1-20260706","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"104632","DOI":"10.1016\/j.oraloncology.2020.104632","article-title":"Screening for oral cancer: Future prospects, research and policy development for Asia","volume":"105","author":"Nagao","year":"2020","journal-title":"Oral Oncol"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/15384047.2015.1070985","article-title":"Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation","volume":"16","author":"Gupta","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/1735-3327.280890","article-title":"Expression of epidermal growth factor receptor in oral and esophageal squamous-cell carcinoma","volume":"17","author":"Shahsavari","year":"2020","journal-title":"Dent Res J"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0001-6519(05)78589-7","article-title":"Immunohistochemistry study of EGFR expression in head and neck squamous cell carcinoma","volume":"56","author":"Altuna Mariezkurrena","year":"2005","journal-title":"Acta Otorrinolaringol Esp"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5732\/cjc.010.10542","article-title":"Therapeutic targeting of epidermal growth factor receptor in human cancer: Successes and limitations","volume":"30","author":"Wykosky","year":"2011","journal-title":"Chin J Cancer"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/pharmaceutics15061653","article-title":"Combination therapy as a promising way to fight oral cancer","volume":"15","author":"Silva","year":"2023","journal-title":"Pharmaceutics"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: Signalling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"100592","DOI":"10.1016\/j.oor.2024.100592","article-title":"Emerging targeted therapies in oral oncology: Focus on EGFR inhibition","volume":"11","author":"Veeraraghavan","year":"2024","journal-title":"Oral Oncol Rep"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"100513","DOI":"10.1016\/j.oor.2024.100513","article-title":"Monitoring changes in the P53 gene mutation to diagnose oral cancer","volume":"10","author":"Lakhsmipriya","year":"2024","journal-title":"Oral Oncol Rep"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccr.2007.10.001","article-title":"Shaping genetic alterations in human cancer: The p53 mutation paradigm","volume":"12","author":"Soussi","year":"2007","journal-title":"Cancer Cell"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3892\/or.2023.8599","article-title":"Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain of function and targeting therapy (Review)","volume":"50","author":"Li","year":"2023","journal-title":"Oncol Rep"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/ol.2015.3833","article-title":"Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition","volume":"11","author":"Kimura","year":"2016","journal-title":"Oncol Lett"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","author":"Perez-Herrero","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"105700","DOI":"10.1016\/j.phrs.2021.105700","article-title":"Cytisine and cytisine derivatives: More than smoking cessation aids","volume":"170","author":"Gotti","year":"2021","journal-title":"Pharmacol Res"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"116210","DOI":"10.1016\/j.biopha.2024.116210","article-title":"Cytisine: State of the art in pharmacological activities and pharmacokinetics","volume":"171","author":"Wang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R17-20260706","first-page":"100384","article-title":"Unravelling the role of key genes in oral cancer progression: A comprehensive","volume":"10","author":"Raghavi","year":"2024","journal-title":"Rev Oral Oncol Rep"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.3233\/TUB-230034","article-title":"Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR, ALK and ROS1 tyrosine kinase inhibitors: An update","volume":"46","author":"Moes-Sosnowska","year":"2024","journal-title":"Tumour Biol"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: Important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem J"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1007\/s00044-014-1090-1","article-title":"In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor","volume":"23","author":"Singh","year":"2014","journal-title":"Med Chem Res"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"155488","DOI":"10.1016\/j.phymed.2024.155488","article-title":"The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K\/Akt signaling pathway: Based on the network pharmacology, molecular docking,in vitro and in vivo experimental validation","volume":"128","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.5808\/gi.21062","article-title":"Molecular docking of bioactive compounds derived from Moringa oleifera with p53 protein in the apoptosis pathway of oral squamous cell carcinoma","volume":"19","author":"Rath","year":"2021","journal-title":"Genomics Inform"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1080\/07391102.2022.2137241","article-title":"Insights into molecular docking and dynamics to reveal therapeutic potential of natural compounds against P53 protein","volume":"41","author":"Malla","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3892\/mmr.2017.6991","article-title":"Cytisine induces apoptosis of HepG2 cells","volume":"16","author":"Yu","year":"2017","journal-title":"Mol Med Rep"},{"key":"R26-20260706","first-page":"1475","article-title":"Cytisine induces endoplasmic reticulum stress caused by calcium overload in HepG2 cells","volume":"39","author":"Yu","year":"2018","journal-title":"Oncol Rep"},{"key":"R27-20260706","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/molecules23123059","article-title":"Cytisine-pterocarpan-derived compounds: Biomimetic synthesis and apoptosis-inducing activity in human breast cancer cells","volume":"23","author":"Peng","year":"2018","journal-title":"Molecules"},{"key":"R28-20260706","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/21691401.2019.1699813","article-title":"Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways","volume":"48","author":"Xu","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"R29-20260706","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/antiox12061159","article-title":"Oxidative stress inducers in cancer therapy: Preclinical and clinical evidence","volume":"12","author":"Nizami","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"R30-20260706","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semcancer.2018.08.010","article-title":"Oxidative stress-modulating drugs have preferential anticancer effects-involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration","volume":"58","author":"Tang","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"R31-20260706","doi-asserted-by":"crossref","first-page":"65","DOI":"10.31557\/APJCP.2019.20.1.65","article-title":"Antimetastatic potential of Garcinone E in human oral cancer cells","volume":"20","author":"Sheela","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"R32-20260706","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/biom10040502","article-title":"Luteolin-7-O-glucoside inhibits oral cancer cell migration and invasion by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway","volume":"10","author":"Velmurugan","year":"2020","journal-title":"Biomolecules"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/jomfp.jomfp_86_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:45:03Z","timestamp":1783345503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/jomfp.jomfp_86_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_86_26","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-03-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}